Mostrar el registro sencillo del ítem

dc.contributor.authorCerdó, Tomás
dc.contributor.authorGarcía Santos, José Antonio 
dc.contributor.authorG. Bermúdez, Mercedes
dc.contributor.authorCampoy Folgoso, Cristina 
dc.date.accessioned2019-05-18T20:45:48Z
dc.date.available2019-05-18T20:45:48Z
dc.date.issued2019-03-15
dc.identifier.citationCerdó, T. [et al.]. The Role of Probiotics and Prebiotics in the Prevention and Treatment of Obesity. Nutrients 2019, 11, 635; doi:10.3390/nu11030635.es_ES
dc.identifier.issn2072-6643
dc.identifier.urihttp://hdl.handle.net/10481/55760
dc.description.abstractObesity is a global pandemic complex to treat due to its multifactorial pathogenesis—an unhealthy lifestyle, neuronal and hormonal mechanisms, and genetic and epigenetic factors are involved. Scientific evidence supports the idea that obesity and metabolic consequences are strongly related to changes in both the function and composition of gut microbiota, which exert an essential role in modulating energy metabolism. Modifications of gut microbiota composition have been associated with variations in body weight and body mass index. Lifestyle modifications remain as primary therapy for obesity and related metabolic disorders. New therapeutic strategies to treat/prevent obesity have been proposed, based on pre- and/or probiotic modulation of gut microbiota to mimic that found in healthy non-obese subjects. Based on human and animal studies, this review aimed to discuss mechanisms through which gut microbiota could act as a key modifier of obesity and related metabolic complications. Evidence from animal studies and human clinical trials suggesting potential beneficial effects of prebiotic and various probiotic strains on those physical, biochemical, and metabolic parameters related to obesity is presented. As a conclusion, a deeper knowledge about pre-/probiotic mechanisms of action, in combination with adequately powered, randomized controlled follow-up studies, will facilitate the clinical application and development of personalized healthcare strategies.es_ES
dc.description.sponsorshipSupported by funds from European Union 7th FP KBBE.2013.2.2-02—MyNewGut Project (“Factors influencing the human gut microbiome and its effect on the development of diet-related diseases and brain development”, Grant Agreement 613979) and from Spanish Ministry of Economy and Competitiveness GD-Brain Projects (SAF2015-69265-c2.2).es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAtribución 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectObesity es_ES
dc.subjectGut microbiotaes_ES
dc.subjectProbioticses_ES
dc.subjectPrebioticses_ES
dc.subjectNutrition es_ES
dc.titleThe Role of Probiotics and Prebiotics in the Prevention and Treatment of Obesityes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.doi10.3390/nu11030635


Ficheros en el ítem

[PDF]

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 3.0 España
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 3.0 España